Details of the Drug
General Information of Drug (ID: DMKFGDI)
Drug Name |
3-(1H-pyrazol-3-yl)benzoic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-(1H-pyrazol-5-yl)benzoic acid; 850375-11-0; 3-(1H-pyrazol-3-yl)benzoic acid; 3-(2H-pyrazol-3-yl)benzoic Acid; Benzoic acid, 3-(1H-pyrazol-3-yl)-; CHEMBL497801; 5-(3-Carboxyphenyl)-1H-pyrazole; PubChem22748; AC1MDTM0; buttpark 44\01-87; 3-pyrazol-5-ylbenzoic acid; 3-pyrazol-3-ylbenzoic acid; SCHEMBL939810; CTK5F3854; CTK7I8615; DTXSID80383762; MolPort-000-142-934; RXZRBZWATRFHCS-UHFFFAOYSA-N; MolPort-009-196-824; 3-(2h-pyrazol-3-yl)-benzoicacid; KS-00002A0D; ZX-AT019147; ZINC4200665; 3-(1H-Pyrazole-3-yl)benzoic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 188.18 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||